Singapore · Delayed Price · Currency is SGD First Sponsor Group Statistics
Total Valuation
SGX:ADN has a market cap or net worth of SGD 1.15 billion. The enterprise value is 2.55 billion.
| Market Cap | 1.15B |
| Enterprise Value | 2.55B |
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
SGX:ADN has 1.13 billion shares outstanding. The number of shares has decreased by -8.94% in one year.
| Current Share Class | 1.13B |
| Shares Outstanding | 1.13B |
| Shares Change (YoY) | -8.94% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 4.29% |
| Owned by Institutions (%) | 0.14% |
| Float | 135.96M |
Valuation Ratios
The trailing PE ratio is 12.23.
| PE Ratio | 12.23 |
| Forward PE | n/a |
| PS Ratio | 3.86 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | 84.39 |
| P/OCF Ratio | 43.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.59, with an EV/FCF ratio of 186.85.
| EV / Earnings | 27.07 |
| EV / Sales | 8.54 |
| EV / EBITDA | 12.59 |
| EV / EBIT | 13.87 |
| EV / FCF | 186.85 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.34 |
| Quick Ratio | 0.41 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 11.80 |
| Debt / FCF | 105.68 |
| Interest Coverage | 1.16 |
Financial Efficiency
Return on equity (ROE) is 4.57% and return on invested capital (ROIC) is 1.75%.
| Return on Equity (ROE) | 4.57% |
| Return on Assets (ROA) | 1.34% |
| Return on Invested Capital (ROIC) | 1.75% |
| Return on Capital Employed (ROCE) | 3.10% |
| Revenue Per Employee | 582,018 |
| Profits Per Employee | 183,632 |
| Employee Count | 513 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 0.14 |
Taxes
In the past 12 months, SGX:ADN has paid 12.23 million in taxes.
| Income Tax | 12.23M |
| Effective Tax Rate | 10.75% |
Stock Price Statistics
The stock price has decreased by -5.56% in the last 52 weeks. The beta is 0.05, so SGX:ADN's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -5.56% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.04 |
| Relative Strength Index (RSI) | 42.48 |
| Average Volume (20 Days) | 3,185 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGX:ADN had revenue of SGD 298.58 million and earned 94.20 million in profits. Earnings per share was 0.08.
| Revenue | 298.58M |
| Gross Profit | 120.95M |
| Operating Income | 103.49M |
| Pretax Income | 113.69M |
| Net Income | 94.20M |
| EBITDA | 118.25M |
| EBIT | 103.49M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 153.03 million in cash and 1.44 billion in debt, giving a net cash position of -1.29 billion or -1.14 per share.
| Cash & Cash Equivalents | 153.03M |
| Total Debt | 1.44B |
| Net Cash | -1.29B |
| Net Cash Per Share | -1.14 |
| Equity (Book Value) | 2.34B |
| Book Value Per Share | 1.76 |
| Working Capital | 517.00M |
Cash Flow
In the last 12 months, operating cash flow was 26.36 million and capital expenditures -12.71 million, giving a free cash flow of 13.65 million.
| Operating Cash Flow | 26.36M |
| Capital Expenditures | -12.71M |
| Free Cash Flow | 13.65M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 40.51%, with operating and profit margins of 34.66% and 33.52%.
| Gross Margin | 40.51% |
| Operating Margin | 34.66% |
| Pretax Margin | 38.08% |
| Profit Margin | 33.52% |
| EBITDA Margin | 39.60% |
| EBIT Margin | 34.66% |
| FCF Margin | 4.57% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 4.56%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 4.56% |
| Dividend Growth (YoY) | 10.71% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 52.47% |
| Buyback Yield | 8.94% |
| Shareholder Yield | 13.50% |
| Earnings Yield | 8.18% |
| FCF Yield | 1.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 11, 2018. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 11, 2018 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
SGX:ADN has an Altman Z-Score of 0.96 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.96 |
| Piotroski F-Score | 4 |